Trial intelligence / Profile preview

Crushed versus whole Zepatier pharmacokinetic comparison

NL-OMON47715Completed

Sponsor
Ziekenhuisapotheek
Start
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of grazoprevir and elbasvir in hepatitis C virus infection, sponsored by Ziekenhuisapotheek. Primary endpoints: AUC0-72h geometric mean ratio and AUC0-inf geometric mean ratio. Started Apr 2019; status: completed.

02

Drugs

grazoprevirelbasvir
03

Conditions

hepatitis C virus infection

Beyond the preview

Go deeper on NL-OMON47715.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON47715.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call